Skip to main content
. Author manuscript; available in PMC: 2008 Apr 1.
Published in final edited form as: Heart Rhythm. 2007 Jan 7;4(5):638–647. doi: 10.1016/j.hrthm.2006.12.046

Figure 5. Ranolazine suppression of BayK8644–induced torsades de pointes in a left ventricular wedge preparation.

Figure 5

A: BayK8644 (1 μM, 60 minutes of exposure) induced spontaneous polymorphic ventricular tachycardia resembling torsades de pointes. B: Ranolazine (1 μM, 30 minutes of exposure) in the continued presence of BayK8644 abolishes ectopy and episodes of torsades de pointes.